UNLIMITED TURBO BULL - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Euronext Paris 12:30:00 2024-05-24 EDT | ||
| 0.425 EUR | -10.53% |
|
| Current month | -25.44% | ||
| 1 month | -29.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 0.425 | -10.53% |
| 24-05-23 | 0.475 | -5.94% |
| 24-05-22 | 0.505 | +2.02% |
| 24-05-21 | 0.495 | -25.56% |
| 24-05-20 | 0.665 | -5.67% |
Real-time Euronext Paris
Last update May 24, 2024 at 12:30 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
Société Générale
|
| 5G72S | |
| ISIN | DE000SW8YDH3 |
| Date issued | 2024-04-12 |
| Strike | 44.03 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.48 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.905 € |
|---|---|
| Lowest since issue | 0.395 € |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.34
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.07%
- Stock Market
- Certificates
- 5G72S Certificat
